Literature DB >> 22595550

Estrogen and the skeleton.

Sundeep Khosla1, Merry Jo Oursler, David G Monroe.   

Abstract

Estrogen is the major hormonal regulator of bone metabolism in women and men. Therefore, there is considerable interest in unraveling the pathways by which estrogen exerts its protective effects on bone. Although the major consequence of the loss of estrogen is an increase in bone resorption, estrogen deficiency is associated with a gap between bone resorption and formation, indicating that estrogen is also important for maintaining bone formation at the cellular level. Direct estrogen effects on osteocytes, osteoclasts, and osteoblasts lead to inhibition of bone remodeling, decreased bone resorption, and maintenance of bone formation, respectively. Estrogen also modulates osteoblast/osteocyte and T-cell regulation of osteoclasts. Unraveling these pleiotropic effects of estrogen may lead to new approaches to prevent and treat osteoporosis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595550      PMCID: PMC3424385          DOI: 10.1016/j.tem.2012.03.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  52 in total

1.  Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.

Authors:  Guitty Eghbali-Fatourechi; Sundeep Khosla; Arunik Sanyal; William J Boyle; David L Lacey; B Lawrence Riggs
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.

Authors:  R Pacifici; C Brown; E Puscheck; E Friedrich; E Slatopolsky; D Maggio; R McCracken; L V Avioli
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 3.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

Authors:  S C Manolagas; R L Jilka
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

4.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

5.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Authors:  R B Kimble; J L Vannice; D C Bloedow; R C Thompson; W Hopfer; V T Kung; C Brownfield; R Pacifici
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Avian osteoclasts as estrogen target cells.

Authors:  M J Oursler; P Osdoby; J Pyfferoen; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

7.  Osteocyte apoptosis and control of bone resorption following ovariectomy in mice.

Authors:  K B Emerton; B Hu; A A Woo; A Sinofsky; C Hernandez; R J Majeska; K J Jepsen; M B Schaffler
Journal:  Bone       Date:  2009-11-17       Impact factor: 4.398

8.  Treatment of postmenopausal osteoporosis with transdermal estrogen.

Authors:  E G Lufkin; H W Wahner; W M O'Fallon; S F Hodgson; M A Kotowicz; A W Lane; H L Judd; R H Caplan; B L Riggs
Journal:  Ann Intern Med       Date:  1992-07-01       Impact factor: 25.391

9.  Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.

Authors:  R Kitazawa; R B Kimble; J L Vannice; V T Kung; R Pacifici
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

Authors:  S Tanaka; N Takahashi; N Udagawa; T Tamura; T Akatsu; E R Stanley; T Kurokawa; T Suda
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more
  196 in total

1.  Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals.

Authors:  D Krishnamoorthy; D M Frechette; B J Adler; D E Green; M E Chan; C T Rubin
Journal:  Osteoporos Int       Date:  2015-09-01       Impact factor: 4.507

Review 2.  The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment.

Authors:  Núria Guañabens; María Jesús Moro-Álvarez; Enrique Casado; Josep Blanch-Rubió; Carlos Gómez-Alonso; Guillermo Martínez Díaz-Guerra; Javier Del Pino-Montes; Carmen Valero Díaz de Lamadrid; Pilar Peris; Manuel Muñoz-Torres
Journal:  Endocrine       Date:  2019-04-08       Impact factor: 3.633

3.  Risk of Nonspine Fractures in Older Adults with Sarcopenia, Low Bone Mass, or Both.

Authors:  Didier Chalhoub; Peggy M Cawthon; Kristine E Ensrud; Marcia L Stefanick; Deborah M Kado; Robert Boudreau; Susan Greenspan; Anne B Newman; Joseph Zmuda; Eric S Orwoll; Jane A Cauley
Journal:  J Am Geriatr Soc       Date:  2015-08-27       Impact factor: 5.562

4.  Associations Between Lean Mass, Muscle Strength and Power, and Skeletal Size, Density and Strength in Older Men.

Authors:  Didier Chalhoub; Robert Boudreau; Susan Greenspan; Anne B Newman; Joseph Zmuda; Andrew W Frank-Wilson; Nayana Nagaraj; Andrew R Hoffman; Nancy E Lane; Marcia L Stefanick; Elizabeth Barrett-Connor; Tien Dam; Peggy M Cawthon; Eric S Orwoll; Jane A Cauley
Journal:  J Bone Miner Res       Date:  2018-06-12       Impact factor: 6.741

5.  17β-estradiol Induces MMP-9 and MMP-13 in TMJ Fibrochondrocytes via Estrogen Receptor α.

Authors:  N Ahmad; S Chen; W Wang; S Kapila
Journal:  J Dent Res       Date:  2018-04-05       Impact factor: 6.116

Review 6.  [Influence of hormone or hormone replacement therapy on bone healing].

Authors:  Friederike Thomasius; Peyman Hadji
Journal:  Unfallchirurg       Date:  2019-07       Impact factor: 1.000

Review 7.  Brain to bone: What is the contribution of the brain to skeletal homeostasis?

Authors:  Anna Idelevich; Roland Baron
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

8.  Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells.

Authors:  Yonatan Amzaleg; Jie Ji; Donlaporn Kittivanichkul; Anna E Törnqvist; Sara Windahl; Elias Sabag; Aysha B Khalid; Hal Sternberg; Michael West; John A Katzenellenbogen; Susan A Krum; Nyam-Osor Chimge; Dustin E Schones; Yankel Gabet; Claes Ohlsson; Baruch Frenkel
Journal:  J Steroid Biochem Mol Biol       Date:  2018-05-08       Impact factor: 4.292

Review 9.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

10.  Stability of mRNA influences osteoporotic bone mass via CNOT3.

Authors:  Chiho Watanabe; Masahiro Morita; Tadayoshi Hayata; Tetsuya Nakamoto; Chisato Kikuguchi; Xue Li; Yasuhiro Kobayashi; Naoyuki Takahashi; Takuya Notomi; Keiji Moriyama; Tadashi Yamamoto; Yoichi Ezura; Masaki Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.